New Harbor Capital Makes Majority Growth Investment in FoodPharma
June 8, 2021
New Harbor Capital completed a majority growth equity investment in Food Technology and Design, LLC (dba FoodPharma), an R&D-focused contract manufacturer of functional and nutritional foods. New Harbor will partner with founder and CEO Glen Marinelli to expand the company’s product categories, capabilities, customers and geographies; FoodPharma operates two California facilities and employs over 90 people.
- Buyers
- New Harbor Capital
- Targets
- Food Technology and Design, LLC (d/b/a FoodPharma)
- Industry
- Food & Beverage
- Location
- California, United States
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
Hidden Harbor Capital Partners Invests in Quaker Valley Foods
January 7, 2025
Food & Beverage
Hidden Harbor Capital Partners has made a strategic control investment in Quaker Valley Foods, a Philadelphia-based protein distributor. The management team will remain in place and Hidden Harbor intends to scale operations and pursue organic growth and acquisitions; debt financing was provided by NXT Capital and Maranon Capital.
-
1315 Capital Backs USpharma Ltd. with Growth Equity Investment
June 30, 2025
Pharmaceuticals
USpharma Ltd., a Miami Lakes-based pharmaceutical development and manufacturing company, received a growth equity investment from Philadelphia-based 1315 Capital. The capital will be used to accelerate development and commercialization of USpharma’s pipeline, expand commercial reach, and scale operations at its 150,000 sq. ft. US-based GMP facility.
-
New Harbor Capital and Origami Capital Recapitalize LGM Pharma
October 1, 2024
Pharmaceuticals
New Harbor Capital completed a single-asset continuation recapitalization of LGM Pharma in partnership with Origami Capital Partners to provide growth capital and facilitate liquidity for existing investors. LGM Pharma is a CDMO and API sourcing/distribution platform with manufacturing and analytical capabilities serving pharmaceutical, biotechnology and compounding pharmacy customers across multiple U.S. facilities.
-
New Harbor Capital Invests in Monroe Biomedical Research
August 30, 2023
Healthcare Services
New Harbor Capital has completed a growth investment in Monroe Biomedical Research (MBR), a clinical trial site business headquartered in Monroe, North Carolina. New Harbor will partner with MBR's founder-led team to scale the company's multi-site clinical research capabilities and expand its patient recruitment and trial execution capacity.
-
New Harbor Capital Completes Growth Investment in Escalon Services
October 25, 2022
Professional Services
Chicago-based private equity firm New Harbor Capital completed a growth investment in Escalon Services, a tech-enabled provider of outsourced accounting, finance, HR and risk solutions for SMBs. The partnership will support Escalon's organic growth, fund strategic acquisitions and investments in technology to scale its essential business services platform.
-
New Harbor Capital Makes Growth Equity Investment in IndeVets
December 9, 2021
Veterinary
Chicago-based private equity firm New Harbor Capital completed a growth equity investment in IndeVets, a Philadelphia-based tech-enabled provider of veterinarian staffing services. The financing will support IndeVets' growth and geographic expansion as it scales its proprietary scheduling platform and expands its network of veterinarians and partner hospitals.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.